Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-09

Clinical Trial Update: Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial tested repurposed approved drugs for treating Yaws presenting with a cutaneous ulcer syndrome. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Yaws, Cutaneous Ulcer | Phase 3 | Status: COMPLETED